Evaluation of the ‘Colli-Pee’ device for self-sampling at home for the detection of sexually transmitted infections, versus a routine clinic-based urine collection in a one-to-one comparison study design

You are here

De Baetselier et al., 2019

Aim: To perform a one-to-one comparison between the sexually transmitted infection (STI) test results obtained with first-void urine collected in the clinic versus at home with Colli-Pee® by Men who have Sex with Men (MSM) in Belgium within the BePrepared study (NCT02552914).

Affiliations: Institute of Tropical Medicine, Antwerp

Summary: The Colli-Pee® device proved to be a feasible and convenient way to collect first-void urine at home by MSM users for STI testing. This may be particularly relevant for populations that need frequent STI testing and patients who prefer home-sampling. Furthermore, the study demonstrated that postal delivery of home-based collected first-void urine with the Colli-Pee® device, does not influence STI detection compared to STI results measured at the clinic.

Evaluation of the ‘Colli-Pee’, a first-void urine collection device for self-sampling at home for the detection of sexually transmitted infections, versus a routine clinic-based urine collection in a one-to-one comparison study design: efficacy and acceptability among MSM in Belgium

Additionally, the following posters report the interim results that led to the publication:

Colli-Pee®: A new device to collect first-void urine at home for molecular detection of STIs

De Baetselier et al, World IUSTI San Paolo, 2017 (Poster)

Aim: Evaluate the use of Colli-Pee® collected urine mailed by regular post for sexually transmitted infection (STI) detection among Men who have Sex with Men (MSM) who participated in a Belgian HIV prevention study

Affiliations: Institute of Tropical Medicine Antwerp - HIV/STI Reference Laboratory (Belgium)

Summary: Colli-Pee® is feasible and a convenient way to collect urine at home for STI testing. This may be particularly relevant for populations that need frequent STI testing (e.g. PrEP users) and patients who prefer home-testing.